Bedeutung von Vitamin D bei MS unter IFN-beta-1b.

 Aktuelle Publikation von Munger KL et al: Ann Clin Transl Neurol. 2014 Aug

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.


Here, we provide mechanistic evidence that an unbalanced 25(OH)D gene expression system may affect MS activity. Our findings support a potential benefit of monitoring and managing vitamin D levels (e.g., through supplementation) in early MS patients treated with IFN-beta-1b.

Der komplette Artikel kann hier abgerufen werden: